|
US7763609B2
(en)
|
2003-12-15 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
ES2476027T3
(es)
|
2005-10-25 |
2014-07-11 |
Shionogi & Co., Ltd. |
Derivados de aminodihidrotriazina
|
|
WO2008133273A1
(ja)
|
2007-04-24 |
2008-11-06 |
Shionogi & Co., Ltd. |
アルツハイマー症治療用医薬組成物
|
|
KR20100017255A
(ko)
|
2007-04-24 |
2010-02-16 |
시오노기 앤드 컴파니, 리미티드 |
환식기로 치환된 아미노다이하이드로싸이아진 유도체
|
|
HRP20151030T1
(hr)
|
2008-01-18 |
2015-11-06 |
Eisai R&D Management Co., Ltd. |
Kondenzirani derivat aminodihidrotiazina
|
|
MX2010013256A
(es)
|
2008-06-13 |
2010-12-21 |
Shionogi & Co |
Derivado heterociclico que contiene azufre que tiene actividad inhibitoria de beta-secretasa.
|
|
AU2009277485B2
(en)
*
|
2008-07-28 |
2013-05-02 |
Eisai R&D Management Co., Ltd. |
Spiroaminodihydrothiazine derivatives
|
|
WO2010038686A1
(ja)
*
|
2008-09-30 |
2010-04-08 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
新規な縮合アミノジヒドロチアジン誘導体
|
|
EP2360155A4
(en)
*
|
2008-10-22 |
2012-06-20 |
Shionogi & Co |
2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
|
|
GB0912778D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydro-oxazine derivatives
|
|
GB0912777D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydropyrimidone derivatives
|
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
|
WO2011044184A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
EP2485920B1
(en)
|
2009-10-08 |
2016-04-27 |
Merck Sharp & Dohme Corp. |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
EP2485591B1
(en)
|
2009-10-08 |
2016-03-23 |
Merck Sharp & Dohme Corp. |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2511269A4
(en)
*
|
2009-12-11 |
2013-04-24 |
Shionogi & Co |
FUSED HETEROCYCLIC COMPOUND HAVING AN AMINO GROUP
|
|
JPWO2011071135A1
(ja)
|
2009-12-11 |
2013-04-22 |
塩野義製薬株式会社 |
オキサジン誘導体
|
|
EP2580200B1
(en)
|
2010-06-09 |
2016-09-14 |
Janssen Pharmaceutica, N.V. |
5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
|
|
CN103261199A
(zh)
|
2010-10-29 |
2013-08-21 |
盐野义制药株式会社 |
萘啶衍生物
|
|
US9018219B2
(en)
|
2010-10-29 |
2015-04-28 |
Shionogi & Co., Ltd. |
Fused aminodihydropyrimidine derivative
|
|
CN103403007B
(zh)
|
2010-12-22 |
2015-12-09 |
詹森药业有限公司 |
用作β-分泌酶(BACE)抑制剂的5,6-二氢-咪唑并[1,2-a]吡嗪-8-基胺衍生物
|
|
GB201100181D0
(en)
*
|
2011-01-06 |
2011-02-23 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
GB201101140D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
SG10201601516QA
(en)
*
|
2011-01-21 |
2016-03-30 |
Eisai R&D Man Co Ltd |
Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
|
|
GB201101139D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
KR102012675B1
(ko)
|
2011-03-09 |
2019-08-21 |
얀센 파마슈티카 엔.브이. |
베타-세크레타제(BACE)의 억제제로서 유용한 3,4-디하이드로-피롤로[1,2-a]피라진-1-일아민 유도체
|
|
EP2694489B1
(en)
|
2011-04-07 |
2017-09-06 |
Merck Sharp & Dohme Corp. |
C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2694521B1
(en)
|
2011-04-07 |
2015-11-25 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
WO2012147763A1
(ja)
|
2011-04-26 |
2012-11-01 |
塩野義製薬株式会社 |
オキサジン誘導体およびそれを含有するｂａｃｅ１阻害剤
|
|
US8604024B2
(en)
|
2011-05-24 |
2013-12-10 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
|
US8598161B2
(en)
|
2011-05-24 |
2013-12-03 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
|
US8927535B2
(en)
*
|
2011-07-06 |
2015-01-06 |
Hoffman-La Roche Inc. |
Cyclopropyl-fused-1,3-thiazepines as BACE1 and/or BACE2 inhibitors
|
|
BR112014004181A2
(pt)
|
2011-08-22 |
2017-06-13 |
Merck Sharp & Dohme |
composto, composição farmacêutica, e, método de tratamento, prevenção, e / ou retardo do início de uma doença ou patologia
|
|
WO2013030713A1
(en)
|
2011-08-31 |
2013-03-07 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3] thiazin-2-amine compounds
|
|
JO3143B1
(ar)
|
2012-04-03 |
2017-09-20 |
Lilly Co Eli |
مركبات تتراهيدرو بيرولو ثيازين
|
|
HUE030534T2
(hu)
|
2012-04-27 |
2017-05-29 |
Eisai R&D Man Co Ltd |
Eljárás 5-(difluormetil)pirazin-2-karbonsav elõállítására és elõállítási intermediere
|
|
WO2013164730A1
(en)
|
2012-05-04 |
2013-11-07 |
Pfizer Inc. |
Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin- 2 -amine compounds as inhibitors of app, bace1 and bace 2.
|
|
GB201212871D0
(en)
|
2012-07-20 |
2012-09-05 |
Eisai Ltd |
Novel compounds
|
|
JP2015529239A
(ja)
|
2012-09-20 |
2015-10-05 |
ファイザー・インク |
アルキル置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
EP2912035A4
(en)
|
2012-10-24 |
2016-06-15 |
Shionogi & Co |
DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY
|
|
US9328124B2
(en)
*
|
2012-10-26 |
2016-05-03 |
Eli Lilly And Company |
BACE inhibitors
|
|
WO2014091352A1
(en)
*
|
2012-12-11 |
2014-06-19 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
|
|
WO2014098831A1
(en)
|
2012-12-19 |
2014-06-26 |
Bristol-Myers Squibb Company |
4,6-diarylaminothiazines as bace1 inhibitors and their use for the reduction of beta-amyloid production
|
|
CA2893333C
(en)
|
2012-12-19 |
2017-10-24 |
Pfizer Inc. |
Carbocyclic-and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
WO2014120658A1
(en)
|
2013-01-29 |
2014-08-07 |
Amgen Inc. |
Fused multicyclic 3-amino-5,6-dihydro-2h-1,4-thiazine derivatives and their use as beta-secretase inhibitors
|
|
ES2769578T3
(es)
|
2013-02-12 |
2020-06-26 |
Buck Inst Res Aging |
Hidantoínas que modulan el procesamiento de APP mediado por BACE
|
|
EP2956458B1
(en)
|
2013-02-13 |
2017-08-09 |
Pfizer Inc |
Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
US9233981B1
(en)
|
2013-02-15 |
2016-01-12 |
Pfizer Inc. |
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
AU2014223334C1
(en)
*
|
2013-03-01 |
2018-10-18 |
Amgen Inc. |
Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
JP6374889B2
(ja)
|
2013-03-08 |
2018-08-15 |
アムジエン・インコーポレーテツド |
β−セクレターゼ阻害剤としての過フッ素化シクロプロピル縮合１，３−オキサジン−２−アミン化合物、及び使用方法
|
|
TWI593692B
(zh)
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
|
BR112015030498A2
(pt)
|
2013-06-12 |
2017-07-25 |
Janssen Pharmaceutica Nv |
derivados 4-amino-6-fenil-5,6-di-hidroimidazo[1,5-a]pirazin-3(2h)-ona como inibidores de beta-secretase (bace)
|
|
AU2014280125B2
(en)
|
2013-06-12 |
2018-03-15 |
Janssen Pharmaceutica Nv |
4-amino-6-phenyl-6,7-dihydro[1,2,3]triazolo[1,5-a]pyrazine derivatives as inhibitors of beta-secretase (BACE)
|
|
JO3318B1
(ar)
*
|
2013-06-18 |
2019-03-13 |
Lilly Co Eli |
مثبطات bace
|
|
US9096615B2
(en)
|
2013-07-30 |
2015-08-04 |
Amgen Inc. |
Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof
|
|
CA2944971C
(en)
|
2014-04-10 |
2019-05-07 |
Pfizer Inc. |
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides
|
|
US9550762B2
(en)
|
2014-08-08 |
2017-01-24 |
Amgen, Inc. |
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
JO3458B1
(ar)
|
2014-11-10 |
2020-07-05 |
H Lundbeck As |
2- أمينو-6- (دايفلوروميثيل) – 5، 5- ديفلورو-6-فينيل-3،4، 5، 6-تيتراهيدروبيريدين كمثبطات bace1
|
|
CR20170187A
(es)
|
2014-11-10 |
2018-02-01 |
H Lundbeck As |
2-Amino-3,5-difluoro-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas en calidad de inhibidores de BACE1 para el tratamiento de la enfermedad de Alzheimer
|
|
MA40941A
(fr)
|
2014-11-10 |
2017-09-19 |
H Lundbeck As |
2-amino-5,5-difluoro-6-(fluorométhyl)-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1
|
|
WO2016096979A1
(en)
|
2014-12-18 |
2016-06-23 |
Janssen Pharmaceutica Nv |
2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2h-pyrrol-5-amine compound inhibitors of beta-secretase
|
|
AR103680A1
(es)
|
2015-02-23 |
2017-05-24 |
Lilly Co Eli |
Inhibidores selectivos de bace1
|
|
US9938266B2
(en)
|
2015-03-19 |
2018-04-10 |
Eli Lilly And Company |
Selective BACE1 inhibitors
|
|
AR104241A1
(es)
|
2015-04-29 |
2017-07-05 |
Lilly Co Eli |
Derivados de tetrahidrofuro tiazina como inhibidores de bace1 selectivos
|
|
WO2017024180A1
(en)
|
2015-08-06 |
2017-02-09 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
TW201717948A
(zh)
|
2015-08-10 |
2017-06-01 |
Ｈ 朗德貝克公司 |
包括給予２－胺基－３，５，５－三氟－３，４，５，６－四氫吡啶的聯合治療
|
|
EP3334738A1
(en)
*
|
2015-08-12 |
2018-06-20 |
H. Lundbeck A/S |
2-amino-7a-phenyl-3,4,4a,5,7,7a-hexahydrofuro[3,4-b]pyridines as bace1 inhibitors
|
|
US10011596B2
(en)
|
2015-08-12 |
2018-07-03 |
H. Lundbeck A/S |
2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors
|
|
EP3353182A1
(en)
|
2015-09-24 |
2018-08-01 |
Pfizer Inc |
Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
|
|
WO2017051294A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides useful as bace inhibitors
|
|
EP3353183A1
(en)
|
2015-09-24 |
2018-08-01 |
Pfizer Inc |
N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3]thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl]amides
|
|
TWI675034B
(zh)
*
|
2016-05-20 |
2019-10-21 |
美商美國禮來大藥廠 |
四氫呋喃并<img align="absmiddle" height="18px" width="27px" file="d10999.TIF" alt="其他非圖式 ed10999.png" img-content="tif" orientation="portrait" inline="yes" giffile="ed10999.png"></img>化合物及其作為選擇性ＢＡＣＥ１抑制劑之用途
|
|
CN109890828A
(zh)
*
|
2016-11-04 |
2019-06-14 |
詹森药业有限公司 |
4,4a,5,7-四氢-3H-呋喃并[3,4-b]吡啶基化合物
|
|
MX387729B
(es)
|
2016-12-15 |
2025-03-18 |
Amgen Inc |
Derivados de dióxido de 1,4-tiazina y dióxido 1,2,4-tiadiazina como inhibidores de beta-secretasa y métodos de uso.
|
|
EP3555084B1
(en)
|
2016-12-15 |
2022-03-16 |
Amgen Inc. |
Thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
EP3555106B1
(en)
|
2016-12-15 |
2022-03-09 |
Amgen Inc. |
Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use
|
|
CA3047286A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
Oxazine derivatives as beta-secretase inhibitors and methods of use
|
|
EP3555085B1
(en)
|
2016-12-15 |
2020-12-02 |
Amgen Inc. |
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
MX2019010659A
(es)
*
|
2017-03-07 |
2019-10-21 |
Janssen Pharmaceutica Nv |
Inhibidores de beta secretasa.
|
|
CN110382506A
(zh)
*
|
2017-03-07 |
2019-10-25 |
詹森药业有限公司 |
β-分泌酶的抑制剂
|
|
KR20190126345A
(ko)
*
|
2017-03-07 |
2019-11-11 |
얀센 파마슈티카 엔.브이. |
베타 세크레타제의 억제제
|
|
EA201992108A1
(ru)
*
|
2017-09-07 |
2020-01-27 |
Янссен Фармацевтика Нв |
Ингибиторы бета-секретазы
|
|
EA201992055A1
(ru)
*
|
2017-09-07 |
2020-01-30 |
Янссен Фармацевтика Нв |
Ингибиторы бета-секретазы
|
|
EA201992076A1
(ru)
*
|
2017-09-07 |
2020-03-19 |
Янссен Фармацевтика Нв |
Ингибиторы бета-секретазы
|
|
CN110590517A
(zh)
*
|
2019-09-24 |
2019-12-20 |
武汉嘉诺康医药技术有限公司 |
一种3，4-二羟基-2′-氯苯乙酮的制备方法
|